Dong Yeol Lee has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Ho Jin Heo

    Division of Applied Life Science, Institute of Agriculture and Life Science (BK21), Gyeongsang National University, Jinju, Republic of Korea

    4 shared publications
  • Hyo Lim Lee

    Division of Applied Life Science (BK21), Institute of Agriculture and Life Science, Gyeongsang National University, Jinju 52828, Republic of Korea

    4 shared publications
  • Han Su Lee

    Division of Applied Life Science (BK21), Institute of Agriculture and Life Science, Gyeongsang National University, Jinju 52828, Republic of Korea

    3 shared publications
  • Hyun-Jin Kim

    Cancer Big Data Center, National Cancer Control Institute, National Cancer Center, Goyang-si, South Korea

    3 shared publications
  • Jong Min Kim

    Aging Research Group, Korea Food Research Institute, Wanju-gun, Jeollabuk-do, South Korea

    3 shared publications
  • Won Min Jeong

    Research & Development Team, Gyeongnam Anti-Aging Research Institute, Sancheong, Republic of Korea

    3 shared publications

Latest Publications

  • Open Access

    Protective effects of Dioscorea bulbifera and Zingiber officinale mixed extracts against glutamate-induced cell death in HT22 cells

    by Seung Woo Im, Won Min Jeong, Dong Yeol Lee, Tae Woo Oh

    This study aimed to evaluate the neuroprotective effects of mixed extracts from Dioscorea bulbifera and Zingiber officinale (DBZO) against glutamate-induced excitotoxicity in HT-22 cells and to elucidate the associated molecular mechanisms. Neurotoxicity and protective effects were assessed using MTT and LDH assays, while cellular morphology was analyzed via microscopy. DBZO extract significantly restored axonal integrity disrupted by glutamate exposure. A DCFDA assay confirmed that DBZO reduced reactive oxygen species (ROS) generation in a concentration-dependent manner, underscoring its antioxidant capacity. Western blot analysis demonstrated that DBZO markedly decreased glutamate-induced neuronal death at 0.25 and 0.5 mg/mL. The observed neuroprotection was associated with the inhibition of the MAPK signaling cascade and the downregulation of apoptotic markers, including Caspase-3 and PARP. Moreover, DBZO activated the PI3K/Akt/mTOR survival pathway, enhancing neuronal viability. It also boosted antioxidant defenses by modulating Keap1 and NQO1 expression, thereby reducing oxidative damage. Collectively, these findings suggest that DBZO confers neuroprotection by regulating oxidative stress and apoptosis through NRf2/NQO-1 signaling. Due to its strong antioxidant and antiapoptotic properties. Graphical Abstract


  • Open Access

    A Combined Extract from Dioscorea bulbifera and Zingiber officinale Mitigates PM2.5-Induced Respiratory Damage by NF-κB/TGF-β1 Pathway

    by In Young Kim, Hyo Lim Lee, Hye Ji Choi, Yeong Hyeon Ju, Yu Mi Heo, Hwa Rang Na, Dong Yeol Lee, Won Min Jeong, Ho Jin Heo

    This research evaluated the protective role of a combined extract of Dioscorea bulbifera and Zingiber officinale (DBZO) against respiratory dysfunction caused by particulate matter (PM2.5) exposure in BALB/c mice. The bioactive compounds identified in the DBZO are catechin, astragalin, 6-gingerol, 8-gingerol, and 6-shogaol. DBZO ameliorated cell viability and reactive oxygen species (ROS) production in PM2.5-stimulated A549 and RPMI 2650 cells. In addition, it significantly alleviated respiratory dysfunction in BALB/c mice exposed to PM2.5. DBZO improved the antioxidant systems in lung tissues by modulating malondialdehyde (MDA) content, as well as levels of reduced glutathione (GSH) and superoxide dismutase (SOD). Likewise, DBZO restored mitochondrial dysfunction by improving ROS levels, mitochondrial membrane potential, and ATP production. Moreover, DBZO modulated the levels of neutrophils, eosinophils, monocytes, and lymphocytes (specifically CD4+, CD8+, and CD4+IL-4+ T cells) in blood and IgE levels in serum. DBZO was shown to regulate the c-Jun N-terminal kinase (JNK) pathway, nuclear factor kappa B (NF-κB) pathway, and transforming growth factor β (TGF-β)/suppressor of mothers against decapentaplegic (Smad) pathway. Histopathological observation indicated that DBZO mitigates the increase in alveolar septal thickness. These findings indicate that DBZO is a promising natural agent for improving respiratory health.


  • Open Access

    Eucommia ulmoides Leaves Alleviate Cognitive Dysfunction in Dextran Sulfate Sodium (DSS)-Induced Colitis Mice through Regulating JNK/TLR4 Signaling Pathway

    by Han Su Lee, Jong Min Kim, Hyo Lim Lee, Min Ji Go, Dong Yeol Lee, Chul-Woo Kim, Hyun-Jin Kim, Ho Jin Heo

    Ulcerative colitis (UC) is one of the inflammatory bowel diseases (IBD) that is characterized by systemic immune system activation. This study was performed to assess the alleviative effect of administering an aqueous extract of Eucommia ulmoides leaves (AEEL) on cognitive dysfunction in mice with dextran sulfate sodium (DSS)-induced colitis. The major bioactive compounds of AEEL were identified as a quinic acid derivative, caffeic acid-O-hexoside, and 3-O-caffeoylquinic acid using UPLC Q-TOF/MSE. AEEL administration alleviated colitis symptoms, which are bodyweight change and colon shortening. Moreover, AEEL administration protected intestinal barrier integrity by increasing the tight junction protein expression levels in colon tissues. Likewise, AEEL improved behavioral dysfunction in the Y-maze, passive avoidance, and Morris water maze tests. Additionally, AEEL improved short-chain fatty acid (SCFA) content in the feces of DSS-induced mice. In addition, AEEL improved damaged cholinergic systems in brain tissue and damaged mitochondrial and antioxidant functions in colon and brain tissues caused by DSS. Also, AEEL protected against DSS-induced cytotoxicity and inflammation in colon and brain tissues by c-Jun N-terminal kinase (JNK) and the toll-like receptor 4 (TLR4) signaling pathway. Therefore, these results suggest that AEEL is a natural material that alleviates DSS-induced cognitive dysfunction with the modulation of gut–brain interaction.


  • Open Access

    Codium fragile Suppressed Chronic PM2.5-Exposed Pulmonary Dysfunction via TLR/TGF-β Pathway in BALB/c Mice

    by Tae Yoon Kim, Jong Min Kim, Hyo Lim Lee, Min Ji Go, Seung Gyum Joo, Ju Hui Kim, Han Su Lee, Won Min Jeong, Dong Yeol Lee, Hyun-Jin Kim, et al.

    This study investigated the ameliorating effect of the aqueous extract of Codium fragile on PM2.5-induced pulmonary dysfunction. The major compounds of Codium fragile were identified as palmitic acid, stearic acid, and oleamide using GC/MS2 and hexadecanamide, oleamide, and 13-docosenamide using UPLC-Q-TOF/MSE. Codium fragile improved pulmonary antioxidant system deficit by regulating SOD activities and reducing GSH levels and MDA contents. It suppressed pulmonary mitochondrial dysfunction by regulating ROS contents and mitochondrial membrane potential levels. It regulated the inflammatory protein levels of TLR4, MyD88, p-JNK, p-NF-κB, iNOS, Caspase-1, TNF-α, and IL-1β. In addition, it improved the apoptotic protein expression of BCl-2, BAX, and Caspase-3 and attenuated the fibrous protein expression of TGF-β1, p-Smad-2, p-Smad-3, MMP-1, and MMP-2. In conclusion, this study suggests that Codium fragile might be a potential material for functional food or pharmaceuticals to improve lung damage by regulating oxidative stress inflammation, cytotoxicity, and fibrosis via the TLR/TGF-β1 signaling pathway.


  • Open Access

    Codium fragile Suppresses PM2.5-Induced Cognitive Dysfunction by Regulating Gut–Brain Axis via TLR-4/MyD88 Pathway

    by Tae Yoon Kim, Jong Min Kim, Hyo Lim Lee, Min Ji Go, Seung Gyum Joo, Ju Hui Kim, Han Su Lee, Dong Yeol Lee, Hyun-Jin Kim, Ho Jin Heo

    This study was conducted to evaluate the cognitive dysfunction improvement effect of aqueous extract of Codium fragile (AECF) by regulating the imbalance of the gut–brain axis in chronic particulate matter (PM)2.5-exposed mice. The physiological compounds of AECF were identified as hexadecanamide, oleamide, octadecanamide, stearidonic acid, and linolenic acid by the ultra-performance liquid chromatography-quadrupole time of flight mass spectrometry (UPLC Q-TOF MSE) analysis. To evaluate the effect of PM2.5 on the antioxidant system, superoxide dismutase (SOD) contents, reduced glutathione (GSH) contents, and malondialdehyde (MDA) contents were measured in colon and brain tissues. AECF significantly ameliorated the imbalance of the antioxidant systems. Also, AECF improved intestinal myeloperoxidase (MPO) activity, the abundance of the gut microbiome, short-chain fatty acids (SCFAs) contents, and tight junction protein expression against PM2.5-induced damage. In addition, AECF prevented PM2.5-induced inflammatory and apoptotic expression via the toll-like receptor-4 (TLR-4)/myeloid differentiation primary response 88 (MyD88) pathway in colon and brain tissues. Additionally, AECF enhanced the mitochondrial function, including the mitochondrial membrane potential (MMP) and reactive oxygen species (ROS) contents in brain tissues. Furthermore, AECF regulated the cholinergic system, such as acetylcholine (ACh) contents, acetylcholinesterase (AChE) activity, and protein expression levels of AChE and choline acetyltransferase (ChAT) in brain tissues. To evaluate the effect of cognitive dysfunction caused by PM2.5-induced intestinal dysfunction, behavior tests such as Y-maze, passive avoidance, and Morris water maze tests were performed. From the results of the behavior tests, AECF ameliorated spatial learning and memory, short-term memory, and long-term learning and memory function. This study confirmed that AECF reduced PM2.5-induced cognitive dysfunction by regulating gut microbiome and inflammation, apoptosis, and mitochondrial function by enhancing the gut–brain axis. Based on these results, this study suggests that AECF, which contains fatty acid amides, might be a potential material for ameliorating PM2.5-induced cognitive dysfunction via gut–brain axis improvement.


  • Study on Residual Characteristics of Mandipropamid and Metalaxyl-M in Cnidium officinale Makino

    by Dong Kyu Jeong, Won Min Jeong, Young Min Goo, Young Sook Kil, Seung Mi Sin, Sang Gon Kim, Do Hyoung Kim, Yeong Jin Kim, Young Sang Kwon, Jin Hyo Kim, et al.